查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446449

血管影像市场规模、份额、趋势分析报告：按模式、最终用途、地区、细分市场预测，2024-2030 年

Vascular Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Ultrasound, Nuclear Medicine), By End-Use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

血管成像市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球血管影像市场规模将达85.2亿美元，2024年至2030年复合年增长率为4.19%。

心血管疾病盛行率的增加和血管扫描设备技术的不断进步极大地推动了血管成像市场的发展。此外，增加血管成像设备开发资金筹措预计将进一步提振市场。

包括 3D 视觉化和手持设备在内的超音波技术的最新开拓预计将有助于血管成像市场的成长。 3D 技术取代 2D 技术使得无需移动换能器即可即时撷取 3D 影像。此外，基于平面波成像的向量多普勒技术的发展也越来越受欢迎。这种方法有效地降低了对焦影像所需的影格速率（更少的扫描线）并且可以更快地完成。

由于患者数量的增加，诊断成像中心的激增为製造商引入更高效的成像技术提供了机会。成像技术的持续发展，例如基于 X 射线的分析和超音波技术，有望扩大血管成像的应用。这些方式在安宁疗护和治疗照护中都受到高度青睐，以提供优质的医疗保健。

血管成像市场报告亮点

  • 按类型划分，由于不同技术提供的各种好处（例如患者安全和缩短週转时间），非侵入性细分市场在 2023 年将占据血管成像市场的最大份额。
  • CT 扫描仪具有诸如改进的空间和时间分辨率、快速程序以及使用 X 光管从不同角度提供多个影像的能力等优点，预计将扩大这种模式的使用。
  • 由于老年族群心血管疾病的高盛行率以及医疗设施的可用性，2023 年的血管影像市场将由北美主导。
  • 由于低收入和中等收入国家心血管疾病的高发病率，预计亚太血管成像市场在预测期内将呈现良好的成长率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章血管影像市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 血管影像市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章血管影像市场：模态估计与趋势分析

  • 2023年及2030年医疗器材市场占有率
  • 细分仪表板
  • 按模式分類的全球血管成像市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章血管影像市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球血管成像市场前景
  • 2018年至2030年市场规模、预测与趋势分析

第六章血管影像市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Siemens Healthineers
    • Abbott Laboratories
    • GE Healthcare
    • Koninklijke Philips NV
    • Hitachi Medical Corporation.
    • Samsung Medison Co., Ltd.
    • Shimadzu Corporation
    • Hologic Inc.
    • Carestream Health Inc.
Product Code: GVR-4-68038-020-0

Vascular Imaging Market Growth & Trends:

The global vascular imaging market size is expected to reach USD 8.52 billion by 2030, registering a CAGR of 4.19% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging is gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Vascular Imaging Market Report Highlights:

  • By type, non-invasive segment held the largest share in vascular imaging market in 2023 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2023, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vascular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cancer and cardiac diseases
      • 3.2.1.2. Favorable government initiatives
      • 3.2.1.3. Trends of preventive healthcare and disease screening programs
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product
      • 3.2.2.2. Increasing use of refurbished products
  • 3.3. Vascular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Vascular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Vascular Imaging Market by Modality Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. CT
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. MRI
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Ultrasound
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Nuclear Medicine
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Vascular Imaging Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Vascular Imaging Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Imaging Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Vascular Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Siemens Healthineers
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Hitachi Medical Corporation.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Samsung Medison Co., Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Shimadzu Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Carestream Health Inc...
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 6 U.S. vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 Canada vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Germany vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Germany vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 15 UK vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 17 France vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 19 Italy vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Spain vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Denmark vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Sweden vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Norway vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 31 China vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 32 China vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Japan vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 36 India vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 37 South Korea vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 38 South Korea vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Australia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 40 Australia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 42 Thailand vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Brazil vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 47 Brazil vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Mexico vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 51 Argentina vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 54 MEA vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 56 South Africa vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 60 UAE vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 Kuwait vascular imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Vascular imaging market: market outlook
  • Fig. 14 Vascular imaging competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Vascular imaging market driver impact
  • Fig. 20 Vascular imaging market restraint impact
  • Fig. 21 Vascular imaging market strategic initiatives analysis
  • Fig. 22 Vascular imaging market: Modality movement analysis
  • Fig. 23 vascular imaging market: Modality outlook and key takeaways
  • Fig. 24 CT market estimates and forecast, 2018 - 2030
  • Fig. 25 MRI estimates and forecast, 2018 - 2030
  • Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 27 Nuclear Medicine estimates and forecast, 2018 - 2030
  • Fig. 28 Vascular imaging Market: End-use movement Analysis
  • Fig. 29 vascular imaging market: End use movement analysis
  • Fig. 30 vascular imaging market: End use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 Imaging Centers market estimates and forecasts,2018 - 2030
  • Fig. 33 Others market estimates and forecasts,2018 - 2030
  • Fig. 34 Global vascular imaging market: Regional movement analysis
  • Fig. 35 Global vascular imaging market: Regional outlook and key takeaways
  • Fig. 36 Global vascular imaging market share and leading players
  • Fig. 37 North America market share and leading players
  • Fig. 38 Europe market share and leading players
  • Fig. 39 Asia Pacific market share and leading players
  • Fig. 40 Latin America market share and leading players
  • Fig. 41 Middle East & Africa market share and leading players
  • Fig. 42 North America, by country
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 71 Market share of key market players- vascular imaging market